Cipla is also working on several peptide-based respiratory products as part of its specialty drug focus in the US. Vohra stressed Cipla's aim to maintain lung leadership by continuously building ...

Cipla's US sales are expected to be adversely impacted by price erosion and supply disruptions for tumor drug Lanreotide, ...

Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the ...

Drug major Cipla has been hit with a penalty of Rs 9.77 crore by the GST Authority for alleged tax violations under the ...

Under the deal, Cipla will be responsible for the manufacturing and marketing of Galvus and its combination brands from 1 January 2026. Galvus brand products are mainly used in the treatment of ...

Indian pharma companies like Dr Reddy’s, Zydus, Cipla, and Sun can sustain low double-digit EPS growth over the medium term.

Explaining the deal further, Cipla informed that the agreement is subject to satisfaction of certain conditions precedent. The company will however continue to market and distribute Galvus branded ...

Cipla Ltd. key Products/Revenue Segments include Pharmaceuticals, Royalty Income, Other Operating Revenue, Export Incentives and Scrap for the year ending 31-Mar-2023.For the quarter ended 30-09-2024, ...

a subsidiary of Cipla, on Wednesday said it has partnered with Swiggy, Zomato and Dunzo for home deliveries of over-the-counter wellness products in the wake of the nationwide lockdown.

Cipla will distribute Sanofi’s CNS portfolio, including Frisium, a leading anti-epileptic drug. Sanofi will retain ownership, import, and manufacture of the CNS products. 04 Mar 2024 The U.S ...